Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma Group (MREO) Times Interest Earned: 2023-2025

Historic Times Interest Earned for Mereo BioPharma Group (MREO) over the last 3 years, with Sep 2025 value amounting to -$357.68.

  • Mereo BioPharma Group's Times Interest Earned fell 1247.07% to -$357.68 in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.42, marking a year-over-year decrease of 165.91%. This contributed to the annual value of -$34.57 for FY2024, which is 250.52% down from last year.
  • Mereo BioPharma Group's Times Interest Earned amounted to -$357.68 in Q3 2025, which was up 18.24% from -$437.46 recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma Group's Times Interest Earned registered a high of -$0.79 during Q2 2023, and its lowest value of -$437.46 during Q2 2025.
  • For the 3-year period, Mereo BioPharma Group's Times Interest Earned averaged around -$94.86, with its median value being -$31.94 (2024).
  • Data for Mereo BioPharma Group's Times Interest Earned shows a maximum YoY tumbled of 4,811.92% (in 2024) over the last 5 years.
  • Over the past 3 years, Mereo BioPharma Group's Times Interest Earned (Quarterly) stood at -$20.19 in 2023, then crashed by 101.72% to -$40.73 in 2024, then slumped by 1,247.07% to -$357.68 in 2025.
  • Its Times Interest Earned stands at -$357.68 for Q3 2025, versus -$437.46 for Q2 2025 and -$62.23 for Q1 2025.